Literature DB >> 19574257

Plasma aminotransferase concentrations in preterm infants.

S Victor1, H Dickinson, M A Turner.   

Abstract

The aim of this study was to generate reference ranges for aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in preterm infants by describing the observed plasma concentration of these enzymes in babies born between 22 and 36 weeks' gestation. A service evaluation was conducted in babies admitted to two large neonatal intensive care units in the UK. 7006 blood samples from 1860 infants admitted to the two units between 2004 and 2008 were included. Extremely premature infants had high plasma enzyme activities when compared to babies at a later corrected gestational age. This may be due to more severe illness immediately after birth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574257     DOI: 10.1136/adc.2008.152454

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  9 in total

Review 1.  Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.

Authors:  Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

2.  Adverse drug reactions in neonates and infants: a population-tailored approach is needed.

Authors:  Karel Allegaert; Johannes N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

3.  Serum Level of Alanine- and Aspartate-Aminotransferase Levels in Newborns in India.

Authors:  Nanda Chhavi; Sachi Ojha; Ashish Awasthi; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-09-23

4.  Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

Authors:  Zhiping Li; Yewei Chen; Qin Li; Di Cao; Wenjing Shi; Yun Cao; Dan Wu; Yiqing Zhu; Yi Wang; Chao Chen
Journal:  Eur J Clin Pharmacol       Date:  2013-01-26       Impact factor: 2.953

5.  Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea.

Authors:  Yuki Ogawa; Mitsuru Irikura; Yuka Kobaru; Mayu Tomiyasu; Yoshie Kochiyama; Mamiko Uriu; Yoichi Ishitsuka; Yuki Kondo; Eiji Yukawa; Noboru Kamada; Hitoshi Ohno; Toshio Yamazaki; Tetsumi Irie
Journal:  Eur J Pediatr       Date:  2014-09-25       Impact factor: 3.183

6.  Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study.

Authors:  Stephen J McWilliam; Daniel J Antoine; Venkata Sabbisetti; Mark A Turner; Tracey Farragher; Joseph V Bonventre; B Kevin Park; Rosalind L Smyth; Munir Pirmohamed
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.

Authors:  Amanda England; Kelly Wade; P Brian Smith; Katherine Berezny; Matthew Laughon
Journal:  Contemp Clin Trials       Date:  2016-03-09       Impact factor: 2.261

8.  Blood Reference Intervals for Preterm Low-Birth-Weight Infants: A Multicenter Cohort Study in Japan.

Authors:  Masayuki Ochiai; Yuki Matsushita; Hirosuke Inoue; Takeshi Kusuda; Dongchon Kang; Kiyoshi Ichihara; Naoki Nakashima; Kenji Ihara; Shouichi Ohga; Toshiro Hara
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

Review 9.  Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment.

Authors:  Karel Allegaert; John van den Anker
Journal:  J Clin Pharmacol       Date:  2021-06       Impact factor: 3.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.